DK352176A - Fremgangsmade til femstilling af acyl-3-oxo-1,2-benzisothiazoliner eller acylsacchariner - Google Patents

Fremgangsmade til femstilling af acyl-3-oxo-1,2-benzisothiazoliner eller acylsacchariner

Info

Publication number
DK352176A
DK352176A DK352176A DK352176A DK352176A DK 352176 A DK352176 A DK 352176A DK 352176 A DK352176 A DK 352176A DK 352176 A DK352176 A DK 352176A DK 352176 A DK352176 A DK 352176A
Authority
DK
Denmark
Prior art keywords
acylsaccharines
benzisothiazolines
oxo
acyl
procedure
Prior art date
Application number
DK352176A
Other languages
English (en)
Inventor
D Mulvey
H Jones
M Zimmerman
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK352176A publication Critical patent/DK352176A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
DK352176A 1975-08-20 1976-08-04 Fremgangsmade til femstilling af acyl-3-oxo-1,2-benzisothiazoliner eller acylsacchariner DK352176A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/606,271 US4195023A (en) 1975-08-20 1975-08-20 2-(2-Furoyl)1,2-benzisothiazole-3-one, 2-(2-furoyl) saccharin, and 2-(2-thenoyl) saccharin

Publications (1)

Publication Number Publication Date
DK352176A true DK352176A (da) 1977-02-21

Family

ID=24427291

Family Applications (1)

Application Number Title Priority Date Filing Date
DK352176A DK352176A (da) 1975-08-20 1976-08-04 Fremgangsmade til femstilling af acyl-3-oxo-1,2-benzisothiazoliner eller acylsacchariner

Country Status (9)

Country Link
US (1) US4195023A (da)
JP (1) JPS5225769A (da)
CH (2) CH627461A5 (da)
DE (1) DE2636599C2 (da)
DK (1) DK352176A (da)
FR (1) FR2321288A1 (da)
GB (1) GB1518404A (da)
NL (1) NL7608676A (da)
SE (1) SE434946B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4276298A (en) * 1978-03-24 1981-06-30 Merck & Co., Inc. 2-Aryl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitors
US4369183A (en) 1979-09-06 1983-01-18 Merck & Co., Inc. 2-Pyridyl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitors
US4315861A (en) * 1979-11-08 1982-02-16 Chinoin Gyogyszer RT Process for O-acylating phenol derivatives and acylating compositions for this purpose
US4323469A (en) * 1980-10-28 1982-04-06 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. Process for O-acylating phenol derivatives and acylating compositions for this purpose
AU637614B2 (en) * 1989-05-04 1993-06-03 Sanofi Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof
US5380737A (en) * 1989-05-04 1995-01-10 Sterling Winthrop Inc. Saccharin derivative proteolytic enzyme inhibitors
US5236917A (en) * 1989-05-04 1993-08-17 Sterling Winthrop Inc. Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
FR2659327A1 (fr) * 1990-03-08 1991-09-13 Centre Nat Rech Scient Derives du benzisothiazolinone-1-dioxyde, utilisables comme inhibiteurs des elastases.
US5306818A (en) * 1990-11-01 1994-04-26 Sterling Winthrop Inc. Tetrahydro 2-saccharinylmerthyl aryl carboxylates
US5512589A (en) * 1990-11-01 1996-04-30 Sterling Winthrop Inc. 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5378720A (en) * 1991-12-19 1995-01-03 Sterling Winthrop Inc. Saccharin derivative proteolytic enzyme inhibitors
AU668694B2 (en) * 1991-12-19 1996-05-16 Sanofi-Synthelabo Saccharin derivative proteolytic enzyme inhibitors
US5187173A (en) * 1991-12-27 1993-02-16 Sterling Winthrop Inc. 2-saccharinylmethyl and 4,5,6,7-tetrahydro-2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5296496A (en) * 1991-12-27 1994-03-22 Sterling Winthrop Inc. 2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
AU653279B2 (en) * 1991-12-30 1994-09-22 Sanofi Novel 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
TW226016B (da) * 1991-12-30 1994-07-01 Sterling Winthrop Inc
GB9626570D0 (en) * 1996-12-20 1997-02-05 Zeneca Ltd Process for making benzisothiazolin-3-ones
US5994396A (en) * 1997-08-18 1999-11-30 Centaur Pharmaceuticals, Inc. Furansulfonic acid derivatives and pharmaceutical compositions containing the same
US7169933B2 (en) * 2003-11-14 2007-01-30 3M Innovative Properties Company N-sulfonylaminocarbonyl containing compounds
US7423155B2 (en) * 2003-11-14 2008-09-09 3M Innovative Properties Company N-sulfonyldicarboximide containing tethering compounds
US7361767B2 (en) * 2003-11-14 2008-04-22 3M Innovative Properties Company N-sulfonyldicarboximide containing tethering compounds
US7943388B2 (en) * 2003-11-14 2011-05-17 3M Innovative Properties Company Acoustic sensors and methods
US7544756B2 (en) * 2005-09-30 2009-06-09 3M Innovative Properties Company Crosslinked polymers with amine binding groups
US7544754B2 (en) 2005-09-30 2009-06-09 3M Innovative Properties Company Crosslinked polymers with amine binding groups
CN113200937B (zh) * 2021-05-14 2022-12-13 郑州大学 一种催化氧化制备1,2-苯并异噻唑啉-3-酮的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1147947B (de) * 1961-07-25 1963-05-02 Knoll Ag Verfahren zur Herstellung neuer 1, 2-Benzisothiazolone
FR1364176A (fr) * 1962-05-18 1964-06-19 Montedison Spa Composés fongiciles à usage agricole

Also Published As

Publication number Publication date
CH627461A5 (de) 1982-01-15
GB1518404A (en) 1978-07-19
SE7608748L (sv) 1977-02-21
DE2636599C2 (de) 1985-10-24
NL7608676A (nl) 1977-02-22
CH625232A5 (da) 1981-09-15
US4195023A (en) 1980-03-25
SE434946B (sv) 1984-08-27
JPS5225769A (en) 1977-02-25
DE2636599A1 (de) 1977-03-03
FR2321288A1 (fr) 1977-03-18
FR2321288B1 (da) 1978-12-22

Similar Documents

Publication Publication Date Title
DK352176A (da) Fremgangsmade til femstilling af acyl-3-oxo-1,2-benzisothiazoliner eller acylsacchariner
DK179675A (da) Fremgangsmade til fremstilling af 6-amino-5-r3-2,4-diaminopyrimidin-3-oxider
DK107876A (da) Fremgangsmade til fremstilling af thiocarbamider
DK164376A (da) Fremgangsmade til fremstilling af 3,4-dihydrospiro-2h-1,3-benzoxaziner
DK554076A (da) Fremgangsmade til fremstilling af 3,4i-dideoxykanamycin ]
DK535476A (da) Fremgangsmade til fremstilling af 7-methoxycephalosporiner
DK150676A (da) Fremgangsmade til fremstilling af krystallinsk natrium-o-formyl-cefamandol
DK356375A (da) Fremgangsmade til fremstilling af 2-thiol-4,5-diphenyloxazol-s-derivater
DK233377A (da) Fremgangsmade til fremstilling af omega-noraromatiske-13,14-dehydro-prostaglandiner
DK390975A (da) Fremgangsmade til fremstilling af omega-nor-cycloalkyl-13,14-dehydroprostaglandiner
DK415576A (da) Fremgangsmade til fremstilling af krystallinsk dipilocarpiniumpamoat
DK399976A (da) Fremgangsmade til fremstilling af aralkylamider
DK29276A (da) Fremgangsmade til fremstilling af 8-bromothieno-triazolo-1,4-diazepiner
DK566277A (da) Fremgangsmaade til fremstilling af 1-aminoalkyl3,4-diphenyl-1h-pyrazoler
DK141584C (da) Fremgangsmaade til fremstilling af slagseje vinylaromat-podecopolymere
DK424676A (da) Fremgangsmade til fremstilling af 2-alkylindan
DK480676A (da) Fremgangsmade til fremstilling af s-alkylphosphordihalogeniddithioater
DK526676A (da) Fremgangsmade til fremstilling af 4-chlor-2-butynyl-m-chlorcarbanilat
DK305076A (da) Fremgangsmade til fremstilling af d,l-pantolacton
DK149803C (da) Fremgangsmaade til fremstilling af 1,2-dichlorethan
DK544476A (da) Fremgangsmade til fremstilling af difluormethyl-1,2,2-trifluorethylether
DK474575A (da) Fremgangsmade til fremstilling af 10,11-dihydro-3-carboxycyproheptadin eller n-oxidet deraf
DK46476A (da) Fremgangsmade til fremstilling af 5-nitrothiazolylimidazolidiner
DK139269B (da) Fremgangsmaade til fremstilling af 4-androsten3,17-dionderivatier
DK554176A (da) Fremgangsmade til fremstilling af 3,4-dideoxykanamycin b

Legal Events

Date Code Title Description
ATS Application withdrawn